• Home
  • Search
  • Comparative evaluation of iStent versus iStent inject W combined with phacoemulsification in open angle glaucoma.
  • Cite Icon13
  • https://doi.org/10.1371/journal.pone.0297514Copy DOI Icon

Comparative evaluation of iStent versus iStent inject W combined with phacoemulsification in open angle glaucoma.

Show More
  • Abstract
  • Highlights & Summary
  • PDF
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

The study aimed to compare the 12-month post-operative outcomes of iStent and iStent inject W (inject W), and the factors associated with their success in open-angle glaucoma. This single-center, retrospective comparative case series evaluated the medical records of patients who underwent iStent (comprising 1 stent) or inject W (comprising 2 stents) implantation with cataract surgery for primary open-angle glaucoma and normal tension glaucoma between January 2019 and March 2022. The 12-month post-operative efficacy outcomes included intraocular pressure (IOP), glaucoma medications, and survival analysis of the probability of success. "Failure" was defined as any of the following conditions compared to baseline: 1) IOP elevation, 2) increased glaucoma medication, or 3) IOP decline not exceeding 20% when glaucoma medication scores were comparable, and 4) need for additional glaucoma surgery. The safety outcomes included intra- and post-operative adverse events and changes in the best-corrected visual acuity and visual field. The study comprised 55 eyes in the iStent and 105 in the inject W groups. At 12 months, treatment success was achieved in 66.0% of iStent and 78.4% of inject W eyes. The mean IOP was lower, and the percent reduction from baseline was equal in iStent-treated eyes (8.0% reduction, 14.8 mmHg to 13.7 mmHg, P<0.01) and inject W-treated eyes (11.9% reduction, 15.0 mmHg to 13.8 mmHg, P<0.01) (between-group comparison, P = 0.23). The mean medication burden decreased significantly from 2.5 to 1.1 for iStent (55.0% reduction, P<0.01) and 2.9 to 1.7 for iStent inject (46.8% reduction, P<0.01), with no significant differences between the two groups (P = 0.17). Both devices exhibited excellent safety. Both devices significantly reduced IOP and glaucoma medication 12 months post-operatively. The outcome measures did not differ significantly between the two groups, and lower baseline IOP was predictive of surgical failure.

Loading PDF

Similar Papers
  • PDF
  • Research Article
  • Citations19

Gonioscopy-assisted transluminal trabeculotomy for open-angle glaucoma with failed incisional glaucoma surgery: two-year results

  • Mar 06, 2023
  • BMC Ophthalmology
  • Yiwei Wang +5
  • Research Article
  • Citations19

Multicenter Effectiveness and Disease Stability Through 3 Years After iStentTrabecular Micro-Bypass with Phacoemulsification in Glaucoma and Ocular Hypertension

  • Sep 01, 2022
  • Clinical Ophthalmology (Auckland, N.Z.)
  • Colin Clement +7
  • Research Article
  • Citations33

Second-Generation Trabecular Micro-Bypass (iStent inject) with Cataract Surgery in Eyes with Normal-Tension Glaucoma: One-Year Outcomes of a Multi-Centre Study

  • Jul 01, 2020
  • Ophthalmology and Therapy
  • Ali Salimi +3
  • Research Article
  • Citations3

Outcomes of Nonpenetrating Versus Penetrating Deep Sclerectomy in Open Angle Glaucoma.

  • May 16, 2024
  • Journal of glaucoma
  • Francesco Giorgio Merlo Pich +3
  • Research Article
  • Citations32

Trabecular microbypass stent implantation in pseudophakic eyes with open-angle glaucoma: Long-term results

  • Jan 29, 2019
  • Journal of Cataract and Refractive Surgery
  • Tanner J Ferguson +6
  • Research Article
  • Citations17

Sutureless tunnel trabeculectomy without peripheral iridectomy: a new modification of the conventional trabeculectomy

  • Jul 18, 2012
  • International Ophthalmology
  • Yadollah Eslami +6
  • Research Article

A study on surgical outcome of glaucoma drainage device by “tunnel and track” technique done in North-Eastern India

  • May 01, 2024
  • Haryana Journal of Ophthalmology
  • Santanu Ganguly +1
  • Research Article
  • Citations11

IStent Trabecular Micro-bypass Stent Implantation Combined with Phacoemulsification for Open-Angle Glaucoma: A 2-Year Post-marketing Surveillance Study in Japan

  • Jan 01, 2022
  • Advances in Therapy
  • Masaru Inatani +2
  • Research Article
  • Citations11

One-year interim comparison of canaloplasty in primary open-angle glaucoma following failed filtering surgery with primary canaloplasty

  • Apr 08, 2016
  • British Journal of Ophthalmology
  • Chen Xin +5
  • Research Article

Effects of Growth and Development on Aqueous Humor Dynamics in Male Dutch Belted Rabbits.

  • Sep 03, 2025
  • Investigative ophthalmology & visual science
  • Vikas Gulati +6
  • Research Article
  • Citations6

Genetic Risk and Phenotype Correlation of Primary Open-Angle Glaucoma Based on Rho-Kinase Gene Polymorphisms

  • May 01, 2021
  • Journal of Clinical Medicine
  • Yong-Woo Kim +7
  • Research Article
  • Citations1

Does trabeculectomy work equally well in different types of glaucoma? A single-center, retrospective, comparative cohort study.

  • Dec 01, 2025
  • Journal francais d'ophtalmologie
  • S-C Hug +6
  • Research Article
  • Citations3

Variations in anterior segment parameters among different phenotypes of polycystic ovary syndrome

  • Sep 27, 2024
  • BMC Ophthalmology
  • Fatma Sumer +6
  • Research Article
  • Citations1

Comparative Results of Trabeculectomy with Mitomycin C in Uveitic Glaucoma versus Primary Open-Angle Glaucoma

  • Jan 01, 2015
  • Journal of the Korean Ophthalmological Society
  • Yeon Ho Lee +2
  • PDF
  • Research Article

Comparison of the results of Ex-PRESS® surgery for primary open-angle glaucoma between high and low preoperative intraocular pressure.

  • Mar 04, 2023
  • International ophthalmology
  • Noriko Katayama +3
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.